Vimarsana
Biggest News Aggregation in the World

Social Performance Scale News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Social Performance Scale. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Social Performance Scale Today - Breaking & Trending Today

Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation - Vimarsana News

Prescription Digital Therapeutic for Schizophrenia Receives FDA Breakthrough Device Designation

The device is currently under clinical trial investigation as an adjunct treatment to standard of care therapy for experiential negative symptoms of schizophrenia.

The Effect of Computer-Assisted Cognitive Remediation Therapy on Cogni - Vimarsana News

The Effect of Computer-Assisted Cognitive Remediation Therapy on Cogni

The Effect of Computer-Assisted Cognitive Remediation Therapy on Cognitive Function, Social Function and Quality of Life in Patients with Vascular Dementia

Minerva Neurosciences, Inc: Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia - Vimarsana News

Minerva Neurosciences, Inc: Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

WALTHAM, Mass., Aug. 22, 2022(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today announced that the

Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia - Vimarsana News

Minerva Neurosciences Submits New Drug Application to FDA for Roluperidone for the Treatment of Negative Symptoms in Patients with Schizophrenia

WALTHAM, Mass., Aug. 22, 2022 -- Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system disorders, today... | August 22, 2022

Digital medicine system may reduce schizophrenia symptoms - Vimarsana News

Digital medicine system may reduce schizophrenia symptoms

A digital medicine system appeared to improve clinical schizophrenia symptoms beyond the effects of oral pharmacotherapy alone, according to study results presented at Psych Congress. “This work uses data from a digital medicine system that consists of tablets of the atypical antipsychotic aripiprazole, embedded with an ingestible event marker,” J. Corey Fowler, PhD, director of

Source: healio.com